Martin Gill, Postdoctoral Researcher

Experimental Therapeutics

Development of radiopharmaceuticals and their application in combination therapy for cancer treatment.

Main Researcher: 


Martin obtained his PhD in Chemistry from the University of Sheffield in 2010 under the supervision of Prof. Jim Thomas and Prof. Giuseppe Battaglia, working on ruthenium compounds as luminescent cellular DNA imaging agents. Obtaining EPSRC and Wellcome Trust Fellowships, he moved across to Biomedical Science in Sheffield with Prof. Carl Smythe to explore the chemical biology and medicinal chemistry of metal polypyridyl complexes. Martin joined the Department of Oncology and Prof Kate Vallis’ group in 2014, where his research involves the development of new radiopharmaceuticals and radiosensitizers for cancer treatment. In his spare time, he supports his hometown rugby club, the Scarlets, and Wales.

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.